Home
Dipna Pharmachem Ltd Share Price History
Dipna Pharmachem Ltd
BSE : 15 Jan, 2025
14.5-0.6 (-4.0%)
Prev Close
15.1
Open Price
14.6
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
99000
Today's High / Low
15.2 / 14.4
52 WK High / Low
16.4 / 6.4
Market Price of Dipna Pharmachem Ltd
1M
1Y
3Y
5Y
Monitoring Dipna Pharmachem Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2018 |
|---|---|
| Sales (Cr.) | 17 |
| Sales YoY Gr. | - |
| Adj EPS | 17.27 |
| YoY Gr. | - |
| Net Profit (Cr.) | 0 |
| BVPS | 130.4 |
Key Financial Parameters
| Parameter | 2018 |
|---|---|
| Return on Capital Emp. % | 7.19 |
| Op. Profit Mgn % | 2.42 |
| Net Profit Mgn % | 0.36 |
| Debt to Equity % | 11.09 |
Latest Shareholding
Promoters Holdings Over Time
About Dipna Pharmachem Ltd
- Dipan Pharmachem Private Limited was incorporated under the provisions of Companies Act, 1956 dated July 19, 2011.
- Subsequently, the name of company changed to 'Dipna Pharmachem Private Limited' on March 29, 2012.
- Later on, the Company converted from Private Limited to Public Limited and consequently, name of Company was changed to 'Dipna Pharmachem Limited' vide fresh Certificate of Incorporation issued by Registrar of Companies, Ahmedabad dated May 25, 2022. Mr. Keyur Shah, being the Promoter, the Company is engaged in trading and distribution of pharmaceutical raw material and chemical formulation products, also known as APIs (Active Pharmaceutical Ingredients).
- Presently, its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovasculars, Anti - Bactaria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.
FAQs for Dipna Pharmachem Ltd Share Price History
What are the key events that typically impact Dipna Pharmachem Ltd's share price history?
Key events that impact Dipna Pharmachem Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Dipna Pharmachem Ltd's share price history?
Stock splits reduce the nominal price of Dipna Pharmachem Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Dipna Pharmachem Ltd?
Dividends can influence Dipna Pharmachem Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Dipna Pharmachem Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Dipna Pharmachem Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Dipna Pharmachem Ltd’s share price history?
To understand Dipna Pharmachem Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Popular Search
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
